Calmare Therapeutics (CTTC) and CAS Medical Systems (CASM) Critical Review

Calmare Therapeutics (OTCMKTS:CTTC) and CAS Medical Systems (NASDAQ:CASM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.

Risk & Volatility

Calmare Therapeutics has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, CAS Medical Systems has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.

Earnings and Valuation

This table compares Calmare Therapeutics and CAS Medical Systems’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Calmare Therapeutics $1.11 million 1.64 -$3.82 million N/A N/A
CAS Medical Systems $21.92 million 3.28 -$5.96 million ($0.27) -9.07

Calmare Therapeutics has higher earnings, but lower revenue than CAS Medical Systems.

Analyst Ratings

This is a summary of recent ratings and target prices for Calmare Therapeutics and CAS Medical Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Calmare Therapeutics 0 0 0 0 N/A
CAS Medical Systems 0 1 0 0 2.00

Institutional & Insider Ownership

0.5% of Calmare Therapeutics shares are held by institutional investors. Comparatively, 27.6% of CAS Medical Systems shares are held by institutional investors. 17.5% of Calmare Therapeutics shares are held by insiders. Comparatively, 37.6% of CAS Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Calmare Therapeutics and CAS Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Calmare Therapeutics N/A N/A N/A
CAS Medical Systems -27.26% N/A -50.97%

About Calmare Therapeutics

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

About CAS Medical Systems

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Receive News & Ratings for Calmare Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calmare Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit